Aclidiniumbromid forbedrer lungefunktion og reducerer åndenød hos patienter med KOL

Charlotte Suppli Ulrik

Aclidiniumbromid forbedrer lungefunktion og reducerer åndenød hos patienter med KOL

Institut for Klinisk Medicin

Abstract

Long-acting bronchodilators are central for treatment of COPD. This short review provides an overview of studies evaluating the efficacy of aclidinium bromide, a long-acting anticholinergic bronchodilator, for the treatment of COPD. Twice-daily dosing of aclidinium leads to clinically important improvements in forced expiratory volume in 1 second, health status, use of rescue medication, day-time dyspnoea and exercise tolerance. The available studies also suggest an effect on night-time dyspnoea and exacerbation rate in patients with COPD. Aclidinium seems to have potential for a significant role in the future management of COPD.

Bidragets oversatte titel	Aclidinium bromide improves the lung function and reduces dyspnoea in patients with COPD.
Originalsprog	Dansk
Tidsskrift	Ugeskrift for Laeger
Vol/bind	176
Udgave nummer	28
Sider (fra-til)	1296-1299
Antal sider	4
ISSN	0041-5782
Status	Udgivet - 7 jul. 2014

Citationsformater

@article{358e314c538a4743b4fc2c48672a1a22,

title = "Aclidiniumbromid forbedrer lungefunktion og reducerer {\aa}nden{\o}d hos patienter med KOL",

abstract = "Long-acting bronchodilators are central for treatment of COPD. This short review provides an overview of studies evaluating the efficacy of aclidinium bromide, a long-acting anticholinergic bronchodilator, for the treatment of COPD. Twice-daily dosing of aclidinium leads to clinically important improvements in forced expiratory volume in 1 second, health status, use of rescue medication, day-time dyspnoea and exercise tolerance. The available studies also suggest an effect on night-time dyspnoea and exacerbation rate in patients with COPD. Aclidinium seems to have potential for a significant role in the future management of COPD.",

author = "Ulrik, {Charlotte Suppli}",

year = "2014",

month = jul,

day = "7",

language = "Dansk",

volume = "176",

pages = "1296--1299",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "28",

}

TY - JOUR

T1 - Aclidiniumbromid forbedrer lungefunktion og reducerer åndenød hos patienter med KOL

AU - Ulrik, Charlotte Suppli

PY - 2014/7/7

Y1 - 2014/7/7

N2 - Long-acting bronchodilators are central for treatment of COPD. This short review provides an overview of studies evaluating the efficacy of aclidinium bromide, a long-acting anticholinergic bronchodilator, for the treatment of COPD. Twice-daily dosing of aclidinium leads to clinically important improvements in forced expiratory volume in 1 second, health status, use of rescue medication, day-time dyspnoea and exercise tolerance. The available studies also suggest an effect on night-time dyspnoea and exacerbation rate in patients with COPD. Aclidinium seems to have potential for a significant role in the future management of COPD.

AB - Long-acting bronchodilators are central for treatment of COPD. This short review provides an overview of studies evaluating the efficacy of aclidinium bromide, a long-acting anticholinergic bronchodilator, for the treatment of COPD. Twice-daily dosing of aclidinium leads to clinically important improvements in forced expiratory volume in 1 second, health status, use of rescue medication, day-time dyspnoea and exercise tolerance. The available studies also suggest an effect on night-time dyspnoea and exacerbation rate in patients with COPD. Aclidinium seems to have potential for a significant role in the future management of COPD.

M3 - Tidsskriftartikel

C2 - 25291997

SN - 0041-5782

VL - 176

SP - 1296

EP - 1299

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 28

ER -

Aclidiniumbromid forbedrer lungefunktion og reducerer åndenød hos patienter med KOL

Abstract

Fingeraftryk

Citationsformater